Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Cumberland Pharmaceuticals Inc
Total Current Assets
Cumberland Pharmaceuticals Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Total Current Assets
$36.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Assets
$57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Assets
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Assets
$42.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Assets
$31.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Assets
$25.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Cumberland Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
36.2m
USD
Based on the financial report for Mar 31, 2024, Cumberland Pharmaceuticals Inc's Total Current Assets amounts to 36.2m USD.
What is Cumberland Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
-6%
Over the last year, the Total Current Assets growth was -17%. The average annual Total Current Assets growth rates for Cumberland Pharmaceuticals Inc have been -10% over the past three years , -9% over the past five years , and -6% over the past ten years .